Top 10 Companies in the 1‑Bromoheptane Market (2026): Market Leaders Powering Global Demand

MARKET INSIGHTS

The Global 1‑Bromoheptane market was valued at USD 12.5 million in 2025. The forecast projects the value to rise to USD 19.8 million by 2034, reflecting a compound annual growth rate of 5.2% between 2025 and 2034.

1‑Bromoheptane (C7H15Br) is a colorless to pale yellow liquid alkyl halide. It is insoluble in water but dissolves readily in common organic solvents such as ethanol and ether. The compound is synthesized primarily by reacting 1‑heptanol with hydrobromic acid or by brominating n‑heptane. It functions as a critical intermediate in organic synthesis, underpinning a range of pharmaceutical and agricultural chemistry applications.

Demand is sustained by the pharmaceutical sector, which employs the chemical in the production of active pharmaceutical ingredients (APIs), and by the agricultural chemistry sector, where it is a key step in synthesising pesticides and herbicides. Its versatility in general organic synthesis also fuels a stable, diversified demand base.

1‑Bromoheptane Market – View in Detailed Research Report

Market Size

In 2025, the market reached USD 12.5 million. The value is forecast to climb to USD 19.8 million by 2034, driven by incremental demand in pharmaceutical and agrochemical applications.

Product Definition

1‑Bromoheptane is an alkyl halide with the formula C7H15Br. It is colourless to pale yellow, insoluble in water, and soluble in organic solvents. The compound is produced via bromination of n‑heptane or by treating 1‑heptanol with hydrobromic acid. The compound serves as a versatile alkylating agent in the synthesis of APIs, agrochemicals, and specialty chemicals.

Top 10 Companies in the 1‑Bromoheptane Market

1. PALCHEM (South Africa)

   Headquarters: Johannesburg, South Africa
   Key Offering: High‑purity 1‑Bromoheptane for pharmaceutical intermediates and fine chemicals

   PALCHEM has established a reputation for delivering consistent, GMP‑grade intermediates. Its production facilities leverage advanced bromination technology, ensuring high yields and minimal impurities.

   Sustainability & Growth Initiatives

   • Investment in closed‑loop solvent recovery systems
   • Compliance with ISO 14001 and ISO 45001 environmental and safety standards
   • Partnerships with pharmaceutical developers to co‑develop low‑hazard process routes

2. Glentham Life Sciences (United Kingdom)

   Headquarters: London, United Kingdom
   Key Offering: Pharmaceutical‑grade 1‑Bromoheptane and custom synthesis services

   Glentham Life Sciences supplies high‑purity intermediates to drug discovery laboratories. Its state‑of‑the‑art purification units enable batch‑to‑batch consistency required for regulatory submissions.

   Sustainability & Growth Initiatives

   • Adoption of green bromination catalysts to reduce hazardous waste
   • Implementation of real‑time monitoring for emissions and energy usage
   • Collaborations with academic institutions on sustainable synthetic chemistry

3. Matrix Fine Chemicals (Germany)

   Headquarters: Munich, Germany
   Key Offering: Specialty‑grade 1‑Bromoheptane for agrochemical and specialty polymer applications

   Matrix Fine Chemicals focuses on high‑purity intermediates for complex synthetic routes. Its German plants are equipped with advanced distillation and recrystallisation lines that meet European GMP and REACH requirements.

   Sustainability & Growth Initiatives

   • Zero‑waste policy for bromination processes
   • Renewable energy sourcing for plant operations
   • Participation in the EU Green Deal’s chemical innovation programme

4. Sontara Organo Industries (India)

   Headquarters: Pune, India
   Key Offering: Cost‑effective 1‑Bromoheptane for regional pharmaceutical and agrochemical manufacturing

   Sontara Organo Industries serves the growing Indian market with scalable production and flexible supply contracts. Its focus on process optimisation has lowered raw material costs while maintaining product quality.

   Sustainability & Growth Initiatives

   • Implementation of water‑recycling systems for bromination baths
   • Adoption of low‑energy catalytic routes
   • Strategic alliances with local agri‑chemical firms to expand distribution

5. Yancheng Longshen Chemical Co., Ltd (China)

   Headquarters: Yancheng, China
   Key Offering: Bulk‑grade 1‑Bromoheptane for domestic and export markets

   Longshen Chemical operates one of the largest bromination facilities in China, supplying both industrial and pharmaceutical customers. Its integrated supply chain supports rapid turnaround times.

   Sustainability & Growth Initiatives

   • Deployment of advanced gas‑scrubbing units to control volatile organic compounds
   • Integration of digital process control for energy optimisation
   • Participation in China’s Chemical Industry Green Transformation Programme

6. Damao Chemical Reagent Factory (China)

   Headquarters: Damao, China
   Key Offering: Medium‑purity 1‑Bromoheptane for fine chemical synthesis

   Damao Chemical focuses on high‑volume production with stringent quality checks. Its facilities incorporate automated distillation and filtration to achieve consistent purity levels.

   Sustainability & Growth Initiatives

   • Investment in solvent‑free bromination processes
   • Waste‑heat recovery systems for plant operations
   • Collaboration with regional pharmaceutical developers for tailored intermediates

7. Wuhan Xinyang Ruihe Chemical Technology Co., Ltd (China)

   Headquarters: Wuhan, China
   Key Offering: Specialty‑grade 1‑Bromoheptane for polymer modifiers and advanced materials

   Ruihe Chemical supplies high‑purity intermediates for emerging material science applications. Its research‑and‑development team works closely with manufacturers of liquid crystals and battery electrolytes.

   Sustainability & Growth Initiatives

   • Adoption of renewable energy sources for production
   • Implementation of closed‑loop recycling for bromine waste
   • Joint ventures with university research labs on next‑generation chemical synthesis

8. Yancheng Sanhe Biochemical Co., Ltd (China)

   Headquarters: Yancheng, China
   Key Offering: Research‑grade 1‑Bromoheptane for academic and laboratory use

   Sanhe Biochemical provides ultra‑pure intermediates for experimental chemistry. Its small‑batch production model allows rapid response to niche research demands.

   Sustainability & Growth Initiatives

   • Low‑emission manufacturing protocols
   • Use of biodegradable packaging for laboratory consumables
   • Partnerships with national science foundations for sustainable chemistry projects

9. Huaian Novotel Technology Co., Ltd (China)

   Headquarters: Huaian, China
   Key Offering: Custom 1‑Bromoheptane formulations for agrochemical intermediates

   Novotel Technology specialises in tailoring intermediates to specific pesticide synthesis routes. Its flexible contract manufacturing model supports both small‑scale trials and large‑volume production.

   Sustainability & Growth Initiatives

   • Implementation of green chemistry principles in synthesis pathways
   • Energy‑efficient distillation processes
   • Collaborations with agribusinesses to develop eco‑friendly crop protection agents

10. Sanmenxia Aoke Chemical Industry Co., Ltd (China)

    Headquarters: Sanmenxia, China
    Key Offering: Bulk 1‑Bromoheptane for industrial chemical manufacturing

    Aoke Chemical delivers cost‑effective intermediates to large‑scale chemical producers. Its production strategy focuses on supply reliability and competitive pricing.

    Sustainability & Growth Initiatives

    • Adoption of waste‑minimisation protocols for bromination processes
    • Investment in digital supply‑chain tracking to reduce logistics emissions
    • Partnerships with regional chemical clusters to enhance local value chains

Download FREE Sample Report

Get Full Report

Outlook

From 2025 to 2034, the market is expected to maintain a steady upward trajectory, driven by the compound’s indispensable role in pharmaceutical and agrochemical synthesis. The shift toward high‑purity grades and the expansion of specialty chemical applications are likely to accelerate value‑add margins.

Future Trends

Emerging research into liquid crystal and battery electrolyte applications suggests a new growth vector for 1‑Bromoheptane. Continued investment in green bromination catalysts and process intensification will reduce environmental footprints while meeting the stringent purity demands of advanced pharmaceuticals and materials science.